SIMARD JOHN (Chief Executive Officer) sold 1.5% of their position (60.90K shares) of XBIOTECH INC. on the open market
Open‑market sale worth $812.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 10/1/2021ACC: 0001209191-21-058475
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
-60.90K
Net shares
Net seller
$812.1K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
60.90K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−6.26K
Price / share
$14.27
Trade value
$89.36K
% of position
0.2%
9/28/2021
4.07M→4.07M
Common Stock
Direct
Shares
−16.40K
Price / share
$13.41
Trade value
$219.80K
% of position
0.4%
9/29/2021
4.07M→4.05M
Common Stock
Direct
Shares
−18.56K
Price / share
$13.07
Trade value
$242.46K
% of position
0.5%
9/30/2021
4.05M→4.03M
Common Stock
Direct
Shares
−19.68K
Price / share
$13.23
Trade value
$260.49K
% of position
0.5%
10/1/2021
4.03M→4.01M
Total
Net shares
−60.90K
Net value
-$812.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2021 | S · Sale | −6.26K | $14.27 | $89.36K | 0.2% | 4.07M | 4.07M |
| Common Stock Direct | 9/29/2021 | S · Sale | −16.40K | $13.41 | $219.80K | 0.4% | 4.07M | 4.05M |
| Common Stock Direct | 9/30/2021 | S · Sale | −18.56K | $13.07 | $242.46K | 0.5% | 4.05M | 4.03M |
| Common Stock Direct | 10/1/2021 | S · Sale | −19.68K | $13.23 | $260.49K | 0.5% | 4.03M | 4.01M |
| Total | −60.90K | -$812.12K | ||||||
Derivative Transactions0
No derivative transactions reported